In the tumor microenvironment, IDO is commonly expressed by myeloid cells and suppresses CD8+T cell activity through multiple mechanisms, including the induction of FOXP3+ regulatory T cells and the inhibition of CD8+T cell function (Munn and Mellor, 2016). This evidence concerns the gene IDO1 and neoplasm.